Replies to post #5249 on Rebus Holdings Inc (RBSH)

[Whale Gunna]

Zacks projected NSPX for a $3 billion dollar market potential for mipsagargin (they project phase III trials in 2019 and commercialization in 2020-21), plus royalties etc.. They projected NSPX share price valuation to be $12 once this occurs ;-) ALL THE DD HERE IS SOOOOOOO QUIET I LOVE IT $$$$$ you have noooooo idea how ballistic this is going once the herd catches on and we get current with a pr... Remember PPC*?!?! .005 to .28 in a week? OWC* sub penny to dollars? EWL* sub penny to .77? RXM* from sub penny to .25+? And nobody is even factoring in the FACT that NSPX has a GAME CHANGING CANCER DRUG something all these other tickers lacked, NSPX also HAS THE BEST SS BY A MILE compared to these other companies and lastly...... CONOR FLANNERY/JLL QUIETLY and I mean QUIETLY sneaks into the NSPX picture with a controlling interest stake in the company.. Things that make go hmmmmmm $$$$ connect the dots folks, I'm adding daily this is simply TO EASY

[Floppyplants]

How's the math work on that LOLOLOL